NAD treatment is the direct administration of nicotinamide adenine dinucleotide, a molecule your cells use to produce energy, repair DNA, and regulate aging. Most commonly delivered as an intravenous (IV) infusion, NAD treatment aims to replenish declining levels of this coenzyme, which naturally drops as you get older. It’s offered at wellness clinics and addiction recovery centers for purposes ranging from anti-aging and cognitive support to helping people through drug and alcohol withdrawal.
What NAD+ Does in Your Body
NAD+ is central to how your cells convert food into usable energy. It acts as a shuttle for electrons during metabolic reactions, carrying them to the part of the cell that generates ATP, your body’s primary fuel molecule. Without adequate NAD+, the entire energy production chain slows down.
Beyond energy, NAD+ fuels two other critical systems. First, it activates a family of proteins called sirtuins, which regulate everything from inflammation to how your genes are expressed. Sirtuins can only function when NAD+ is available as a co-substrate, meaning low NAD+ effectively shuts them down. Second, NAD+ powers a group of DNA repair enzymes. When your DNA sustains damage, these enzymes consume NAD+ to recruit repair crews to the damage site. Chronic DNA damage, which increases with age, steadily drains the NAD+ supply.
This creates a problem that compounds over time. As NAD+ levels fall, sirtuin activity drops, mitochondrial function declines, and DNA damage accumulates faster than it can be repaired. Researchers have described this as a “downward spiral” where NAD+ depletion is the central trigger. The logic behind NAD treatment is straightforward: restore the molecule and break the cycle.
How NAD Treatment Is Administered
The most common form is an IV infusion, where NAD+ is dissolved in saline and delivered directly into the bloodstream. NAD+ itself cannot be absorbed through the gut or taken up directly by cells when swallowed, so IV delivery bypasses the digestive system entirely. Oral supplements use precursor molecules (nicotinamide riboside or NMN) that the body must convert into NAD+ after absorption, a process that involves interference from gut bacteria and significant breakdown in the liver before the compounds reach circulation.
A typical IV session uses either 250 mg infused over about 2 hours or 500 mg infused over about 4 hours. Plasma NAD+ levels rise within 2 hours of starting an infusion, with increased urinary NAD+ concentrations measurable around 6 hours later. Some clinics recommend weekly or monthly sessions depending on the goal, whether that’s a short detox protocol or ongoing wellness maintenance.
NAD for Addiction and Withdrawal
One of the earliest clinical uses of NAD treatment was for substance abuse recovery. The theory is that chronic drug and alcohol use depletes NAD+ in the brain, impairing the neurotransmitter systems involved in mood, motivation, and craving. Restoring NAD+ may help brain cells recover healthier function more quickly.
A retrospective analysis of 60 patients found that IV NAD+ significantly reduced self-reported craving ratings associated with both opioid and alcohol withdrawal. Follow-up data over 12 to 20 months showed that craving severity remained lower, suggesting potential as a longer-term strategy for preventing relapse. The approach is typically used alongside other recovery supports, not as a standalone treatment. Research in this area is still limited in scale, but the early clinical data has made NAD infusions a fixture at many addiction treatment centers.
Anti-Aging and Mitochondrial Health
The anti-aging case for NAD treatment centers on mitochondria. When sirtuin activity declines due to low NAD+, mitochondrial biogenesis (the creation of new mitochondria) slows, oxidative metabolism weakens, and antioxidant defenses falter. Animal research has shown that restoring NAD+ levels reactivates sirtuins, which in turn promote mitochondrial repair and the clearance of damaged mitochondria through a process called mitophagy.
In aging mice, researchers found that declining NAD+ led to a “pseudohypoxic state” where cells behaved as though they were oxygen-starved even when they weren’t. This disrupted the signaling chain needed to maintain mitochondrial gene expression. Boosting NAD+ reversed this state and restored normal mitochondrial function. In worms, activating the sirtuin pathway through NAD+ precursors extended lifespan, an effect that disappeared when the mitochondrial stress-response pathway was genetically disabled.
Whether these animal findings translate to meaningful anti-aging effects in humans remains an open question. No large-scale clinical trials have demonstrated that NAD infusions slow human aging in measurable ways, but the biological rationale is well-supported.
Cognitive Benefits
Animal studies have also explored NAD+ for brain health. In rats with reduced blood flow to the brain (a model for the kind of chronic low-grade oxygen deprivation that can cause cognitive decline), daily NAD+ injections for 8 weeks rescued learning and memory deficits. Treated rats navigated mazes faster and spent more time in the correct zones during memory tests compared to untreated animals.
The mechanism appears to involve both mitochondrial protection and reduced neuroinflammation. NAD+ treatment lowered levels of several inflammatory molecules in brain tissue, reduced the activation of immune cells in the brain called microglia, and decreased the production of damaging reactive oxygen species in the cortex and hippocampus. These effects were tied to the same sirtuin pathway involved in mitochondrial health. While promising, this research has been conducted in animals, and controlled human trials on NAD+ for cognitive function are still lacking.
Side Effects and Safety Concerns
NAD infusions are not painless or risk-free. Common side effects during or shortly after infusion include nausea, headache, dizziness, and vomiting. These tend to resolve once the infusion is slowed or stopped, and clinics typically manage them by adjusting the drip rate.
A more serious concern involves the quality of the NAD+ being infused. The FDA issued a warning in October 2024 noting that some compounding pharmacies were using food-grade NAD+ to prepare injectable products. Food-grade ingredients are not suitable for sterile drug compounding because they carry a high risk of contamination with bacteria and endotoxins. The FDA reported receiving adverse event reports of severe chills, shaking, vomiting, and fatigue following NAD+ injections, reactions consistent with endotoxin contamination. Some of these cases required medical treatment. If you’re considering NAD infusions, the source and pharmaceutical grade of the NAD+ matters significantly.
Cost and What to Expect
A single NAD+ infusion session typically costs between $200 and $1,500, depending on the dose, the clinic, and geographic location. Sessions last anywhere from 2 to 4 hours, during which you sit with an IV line while the solution drips slowly. Faster infusion rates tend to cause more side effects, which is why clinics keep the pace gradual.
Some clinics structure treatment as a package of multiple sessions over consecutive days, particularly for addiction protocols, while others offer monthly maintenance infusions for wellness and anti-aging purposes. NAD treatment is not covered by insurance. It is classified as an elective wellness service, and the FDA has not approved NAD+ infusions for any specific medical condition.
Oral Precursors as an Alternative
For people unwilling to commit to the time and cost of IV infusions, oral NAD+ precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) offer a more accessible option. These supplements are converted into NAD+ after absorption, though the process is less efficient. Gut bacteria interfere with absorption, and the liver metabolizes a significant portion before it reaches the rest of the body.
Interestingly, one preliminary study found that NR delivered intravenously increased peak blood NAD+ levels by about 20.7% relative to baseline, actually outperforming IV NAD+ itself at the 3-hour mark. This suggests that how the body processes and distributes NAD+ is more complex than simply flooding the bloodstream with the finished molecule. The optimal delivery method is still an active area of investigation, and neither oral supplements nor IV infusions have a definitive edge backed by large human trials.